Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Tributyrin Supplementation on Glycemic Control, Inflammation, and Cardiovascular Risk in Patients With Type 2 Diabetes

NCT07503548 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT07503548
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07503548 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Tributyrin Supplementation on Glycemic Control, Inflammation, and Cardiovascular Risk in Patients With Type 2 Diabetes
Lead sponsor
Ain Shams University
Phase
Phase 3
Overall status
Not yet recruiting
Start date
March 26, 2026
Completion date
August 26, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabete mellitus